Add to ORKGLong lasting clinical respo for advanced uterine leiom o t f el d nign leiomyomas, smooth muscle tumors of uncertain malignant potential, and leiomyosarcomas (LMS). The se-best results are doxorubicin with or without ifosfamide, gemcitabine and docetaxel and, more recently, trabec
Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aime...
Uterine leiomyomas (fibroids or myomas) are benign tumors of the uterus and are clinically apparent ...
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1121-6. Epub 2007 Nov 6. Uterine smooth muscle tumor of unc...
Introduction: Pharmacological treatment plays a major role in the management of advanced, persistent...
The treatment of advanced uterine leiomyosarcomas (U-LMS) represents a considerable challenge. Radio...
Unfortunately, uterine leiomyosarcoma still has a poor prognosis. The National Cancer Institute repo...
Simple Summary Uterine leiomyosarcoma (uLMS) is a rare and aggressive mesenchymal malignancy. Althou...
Copyright © 2015 Frédéric Amant et al.This is an open access article distributed under the Creativ...
International audienceBackground: Uterine leiomyosarcomas (U-LMSs) and soft tissue leiomyosarcomas (...
Uterine smooth muscle tumors of unknown malignant potential [STUMP]s are neoplasms with pathological...
Uterine leiomyomas (also called myomata or fibroids) are the most common gynecologic tumors in the U...
Leiomyomas are the most common benign gynecological tumors observed during the reproductive period. ...
Uterine sarcomas comprise a group of rare tumors with differing tumor biology, natural history and r...
Background: Uterine leiomyosarcoma (uLMS) is a rare tumor that accounts for 1% of all uterine malign...
Session: Gynecologic and Obstetric Pathology (FREE)This journal issue entitled: United States & Cana...
Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aime...
Uterine leiomyomas (fibroids or myomas) are benign tumors of the uterus and are clinically apparent ...
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1121-6. Epub 2007 Nov 6. Uterine smooth muscle tumor of unc...
Introduction: Pharmacological treatment plays a major role in the management of advanced, persistent...
The treatment of advanced uterine leiomyosarcomas (U-LMS) represents a considerable challenge. Radio...
Unfortunately, uterine leiomyosarcoma still has a poor prognosis. The National Cancer Institute repo...
Simple Summary Uterine leiomyosarcoma (uLMS) is a rare and aggressive mesenchymal malignancy. Althou...
Copyright © 2015 Frédéric Amant et al.This is an open access article distributed under the Creativ...
International audienceBackground: Uterine leiomyosarcomas (U-LMSs) and soft tissue leiomyosarcomas (...
Uterine smooth muscle tumors of unknown malignant potential [STUMP]s are neoplasms with pathological...
Uterine leiomyomas (also called myomata or fibroids) are the most common gynecologic tumors in the U...
Leiomyomas are the most common benign gynecological tumors observed during the reproductive period. ...
Uterine sarcomas comprise a group of rare tumors with differing tumor biology, natural history and r...
Background: Uterine leiomyosarcoma (uLMS) is a rare tumor that accounts for 1% of all uterine malign...
Session: Gynecologic and Obstetric Pathology (FREE)This journal issue entitled: United States & Cana...
Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aime...
Uterine leiomyomas (fibroids or myomas) are benign tumors of the uterus and are clinically apparent ...
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1121-6. Epub 2007 Nov 6. Uterine smooth muscle tumor of unc...